New non-drug technologies for lymphedema associated with breast cancer: a review

• Egile Nagusiak: Tatiana V. Apkhanova (Egilea), Tatiana V. Konchugova (Egilea), Detelina B. Kulchitskaya (Egilea), Olga V. Yurova (Egilea), Elena M. Styazhkina (Egilea), Tatyana V. Marfina (Egilea), Lev G. Agasarov (Egilea), Valeriia A. Vasileva (Egilea), Elena S. Berezkina (Egilea)
• Formatua: Liburua
• Argitaratua: Ministry of Health of the Russian Federation. National Medical Research Center of Rehabilitation and Balneology, 2024-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

INTRODUCTION. Breast Cancer-Related Lymphedema (BCRL) is the most common complication after radical treatment of breast cancer (BC). Currently, there are no molecular therapeutic targets whose pharmacologic action could prevent edema, making it necessary to study the efficacy of non-pharmacologic te...